About Us

GEUS Technology

Aniling owns the GEUS technology, which unifies genetic and epigenetic sequencing and provides end-to-end solutions for the right treatment decisions in oncology. Based on GEUS, Aniling is developing a set of products for cancer diagnostic.

GEUS-CLL

The first Aniling product is the most comprehensive Chronic Lymphocytic Leukemia Next Generation Sequencing diagnostics panel. The GEUS-CLL delivers accurate staging and treatment decisions. Aniling S.L. provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals.

Latest News

world colorectal cancer day blue ribbon

World Colorectal Cancer Day

Yesterday was World Colorectal Cancer Day, the most frequent tumor in the Spanish Population and the second cause of cancer death worldwide, leading to almost 1 million deaths per year. …

World Cancer Day Patitent care

Today is World Cancer Day

World Cancer Day aims to prevent millions of deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against …